The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Healthcare Nanotechnology (Nanomedicine) Market Research Report 2025

Global Healthcare Nanotechnology (Nanomedicine) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903903

No of Pages : 108

Ask Your Query

Synopsis

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

The global Healthcare Nanotechnology (Nanomedicine) market was valued at US$ 205850 million in 2023 and is anticipated to reach US$ 256040 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Healthcare Nanotechnology (Nanomedicine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare Nanotechnology (Nanomedicine).

Report Scope

The Healthcare Nanotechnology (Nanomedicine) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Healthcare Nanotechnology (Nanomedicine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Healthcare Nanotechnology (Nanomedicine) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Amgen
  • Teva Pharmaceuticals
  • Abbott
  • UCB
  • Roche
  • Celgene
  • Sanofi
  • Merck & Co
  • Biogen
  • Stryker
  • Gilead Sciences
  • Pfizer
  • 3M Company
  • Johnson & Johnson
  • SmitH& Nephew
  • Leadiant Biosciences
  • Kyowa Hakko Kirin
  • Takeda
  • Ipsen
  • Endo International

Segment by Type

  • Nanomedicine
  • Nano Medical Devices
  • Nano Diagnosis
  • Other

Segment by Application

  • Anticancer
  • CNS Product
  • Anti-infective
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare Nanotechnology (Nanomedicine) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Healthcare Nanotechnology (Nanomedicine) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Perspective (2019-2030)
2.2 Healthcare Nanotechnology (Nanomedicine) Growth Trends by Region
2.2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Region (2019-2024)
2.2.3 Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Region (2025-2030)
2.3 Healthcare Nanotechnology (Nanomedicine) Market Dynamics
2.3.1 Healthcare Nanotechnology (Nanomedicine) Industry Trends
2.3.2 Healthcare Nanotechnology (Nanomedicine) Market Drivers
2.3.3 Healthcare Nanotechnology (Nanomedicine) Market Challenges
2.3.4 Healthcare Nanotechnology (Nanomedicine) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Revenue
3.1.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Revenue (2019-2024)
3.1.2 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Players (2019-2024)
3.2 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare Nanotechnology (Nanomedicine) Revenue
3.4 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio
3.4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare Nanotechnology (Nanomedicine) Revenue in 2023
3.5 Healthcare Nanotechnology (Nanomedicine) Key Players Head office and Area Served
3.6 Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service
3.7 Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare Nanotechnology (Nanomedicine) Breakdown Data by Type
4.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Type (2019-2024)
4.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Type (2025-2030)
5 Healthcare Nanotechnology (Nanomedicine) Breakdown Data by Application
5.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Application (2019-2024)
5.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size (2019-2030)
6.2 North America Healthcare Nanotechnology (Nanomedicine) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2019-2024)
6.4 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size (2019-2030)
7.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2019-2024)
7.4 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size (2019-2030)
8.2 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2019-2024)
8.4 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size (2019-2030)
9.2 Latin America Healthcare Nanotechnology (Nanomedicine) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2019-2024)
9.4 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size (2019-2030)
10.2 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2019-2024)
10.4 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Healthcare Nanotechnology (Nanomedicine) Introduction
11.1.4 Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Introduction
11.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Healthcare Nanotechnology (Nanomedicine) Introduction
11.3.4 Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Detail
11.4.2 UCB Business Overview
11.4.3 UCB Healthcare Nanotechnology (Nanomedicine) Introduction
11.4.4 UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Healthcare Nanotechnology (Nanomedicine) Introduction
11.5.4 Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Celgene
11.6.1 Celgene Company Detail
11.6.2 Celgene Business Overview
11.6.3 Celgene Healthcare Nanotechnology (Nanomedicine) Introduction
11.6.4 Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.6.5 Celgene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Healthcare Nanotechnology (Nanomedicine) Introduction
11.7.4 Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Detail
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Healthcare Nanotechnology (Nanomedicine) Introduction
11.8.4 Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Detail
11.9.2 Biogen Business Overview
11.9.3 Biogen Healthcare Nanotechnology (Nanomedicine) Introduction
11.9.4 Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Detail
11.10.2 Stryker Business Overview
11.10.3 Stryker Healthcare Nanotechnology (Nanomedicine) Introduction
11.10.4 Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Detail
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Introduction
11.11.4 Gilead Sciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Healthcare Nanotechnology (Nanomedicine) Introduction
11.12.4 Pfizer Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Detail
11.13.2 3M Company Business Overview
11.13.3 3M Company Healthcare Nanotechnology (Nanomedicine) Introduction
11.13.4 3M Company Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Introduction
11.14.4 Johnson & Johnson Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.14.5 Johnson & Johnson Recent Development
11.15 SmitH& Nephew
11.15.1 SmitH& Nephew Company Detail
11.15.2 SmitH& Nephew Business Overview
11.15.3 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Introduction
11.15.4 SmitH& Nephew Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.15.5 SmitH& Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Detail
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Introduction
11.16.4 Leadiant Biosciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Detail
11.17.2 Kyowa Hakko Kirin Business Overview
11.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Introduction
11.17.4 Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.17.5 Kyowa Hakko Kirin Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Healthcare Nanotechnology (Nanomedicine) Introduction
11.18.4 Takeda Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.18.5 Takeda Recent Development
11.19 Ipsen
11.19.1 Ipsen Company Detail
11.19.2 Ipsen Business Overview
11.19.3 Ipsen Healthcare Nanotechnology (Nanomedicine) Introduction
11.19.4 Ipsen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.19.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Detail
11.20.2 Endo International Business Overview
11.20.3 Endo International Healthcare Nanotechnology (Nanomedicine) Introduction
11.20.4 Endo International Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2019-2024)
11.20.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock